Sotera Price Sales Ratio from 2010 to 2024

SHC Stock  USD 12.82  0.41  3.30%   
Sotera Health's Price Sales Ratio is decreasing over the years with slightly volatile fluctuation. Overall, Price Sales Ratio is expected to go to 7.49 this year. During the period from 2010 to 2024 Sotera Health Price Sales Ratio annual values regression line had geometric mean of  7.30 and mean square error of  2.78. View All Fundamentals
 
Price Sales Ratio  
First Reported
2010-12-31
Previous Quarter
4.51256929
Current Value
7.49
Quarterly Volatility
1.84953554
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sotera Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sotera Health's main balance sheet or income statement drivers, such as Interest Expense of 111.9 M, Income Tax Expense of 57.4 M or Minority Interest of 0.0, as well as many indicators such as Price To Sales Ratio of 7.49, Dividend Yield of 0.0501 or PTB Ratio of 10.14. Sotera financial statements analysis is a perfect complement when working with Sotera Health Valuation or Volatility modules.
  
Check out the analysis of Sotera Health Correlation against competitors.

Latest Sotera Health's Price Sales Ratio Growth Pattern

Below is the plot of the Price Sales Ratio of Sotera Health Co over the last few years. It is Sotera Health's Price Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sotera Health's overall financial position and show how it may be relating to other accounts over time.
Price Sales Ratio10 Years Trend
Slightly volatile
   Price Sales Ratio   
       Timeline  

Sotera Price Sales Ratio Regression Statistics

Arithmetic Mean7.64
Geometric Mean7.30
Coefficient Of Variation24.21
Mean Deviation1.22
Median8.28
Standard Deviation1.85
Sample Variance3.42
Range7.1752
R-Value(0.50)
Mean Square Error2.78
R-Squared0.25
Significance0.06
Slope(0.20)
Total Sum of Squares47.89

Sotera Price Sales Ratio History

2024 7.49
2023 4.51
2022 2.32
2021 7.06
2020 9.5
2019 9.17

About Sotera Health Financial Statements

Sotera Health stakeholders use historical fundamental indicators, such as Sotera Health's Price Sales Ratio, to determine how well the company is positioned to perform in the future. Although Sotera Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sotera Health's assets and liabilities are reflected in the revenues and expenses on Sotera Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sotera Health Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Sales Ratio 4.51  7.49 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sotera Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sotera Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sotera Health Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sotera Health Co Stock:
Check out the analysis of Sotera Health Correlation against competitors.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sotera Health. If investors know Sotera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sotera Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.62)
Earnings Share
0.25
Revenue Per Share
3.969
Quarterly Revenue Growth
0.085
Return On Assets
0.0768
The market value of Sotera Health is measured differently than its book value, which is the value of Sotera that is recorded on the company's balance sheet. Investors also form their own opinion of Sotera Health's value that differs from its market value or its book value, called intrinsic value, which is Sotera Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sotera Health's market value can be influenced by many factors that don't directly affect Sotera Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sotera Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sotera Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sotera Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.